5.31
前日終値:
$5.31
開ける:
$5.315
24時間の取引高:
1,225
Relative Volume:
0.03
時価総額:
$79.67M
収益:
$117.93M
当期純損益:
$5.00M
株価収益率:
40.41
EPS:
0.1314
ネットキャッシュフロー:
$-12.91M
1週間 パフォーマンス:
+1.34%
1か月 パフォーマンス:
+460.24%
6か月 パフォーマンス:
+585.12%
1年 パフォーマンス:
+247.06%
Intercure Ltd Stock (INCR) Company Profile
Compare INCR vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
INCR
Intercure Ltd
|
5.31 | 77.42M | 117.93M | 5.00M | -12.91M | 0.1314 |
|
TAK
Takeda Pharmaceutical Co Adr
|
19.05 | 58.31B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 43.22B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.36 | 40.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
73.02 | 30.15B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
497.27 | 21.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-05-18 | アップグレード | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd (INCR) 最新ニュース
InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement - markets.businessinsider.com
InterCure Regains Nasdaq Compliance - marketscreener.com
InterCure Regains Nasdaq Compliance After Delisting Warning - TipRanks
Nasdaq closes delisting matter for InterCure (NASDAQ: INCR) - Stock Titan
InterCure Ltd. (NASDAQ: INCR) Share Price, INCR Stock News, INCR Share Price & Updates - Kalkine
INCR Q2 2023 Earnings: EPS Beat Delivers 28.7% Surprise as Stock Gains 1.76%Earnings Cycle Report - vinanet.vn
InterCure (NASDAQ: INCR) CEO's $2.1M unit stake awaits shareholder approval - Stock Titan
InterCure Raises $5 Million in August Private Placement to Rebuild Nir Oz Facility - The Globe and Mail
Intercure (INCR) CEO joins new cash raise to help fund Nir Oz rebuild - Stock Titan
InterCure Secures NIS 230 Million War-Damage Settlement to Rebuild Nir Oz Facility - The Globe and Mail
InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. - marketscreener.com
InterCure settles tax claim for $77M after October 7 attack - Investing.com Canada
InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages - Yahoo Finance
Intercure (INCR) Chart: Adds 0.23% to Close at $0.87 in the Current Update; Technical Setup: Traders Can Monitor the $0.83-$0.91 Range in Latest TradingMax Pain Level - dars.gov.et
InterCure announces 1-for-5 reverse stock split starting Monday By Investing.com - Investing.com Australia
Intercure (NASDAQ: INCR) issues stock for ISHI deal's first closing - Stock Titan
BRIEF-Intercure Ltd. Announces 1-For-5 Reverse Share Split - Bitget
InterCure announces 1-for-5 reverse stock split starting Monday - Investing.com
InterCure Ltd. Announces 1-for-5 Reverse Share Split - The Manila Times
Intercure Ltd. (INCR) Slips to $0.96: Support Test Looms as Cannabis Stock Faces PressureRVOL Spike - dars.gov.et
InterCure Ltd (INCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alon Shmuel Granot Net Worth (2026) - GuruFocus
InterCure Shareholders Approve Proposal at August 11 Extraordinary Meeting - TipRanks
InterCure holds extraordinary shareholder meeting - Bitget
InterCure Ltd. (INCR) shareholders back proposal at August 11, 2026 special meeting - Stock Titan
Intercure (INCR) Advances 5.91% to $0.98, Approaching Key Resistance at $1.03Factor Crowding - vinanet.vn
InterCure Ltd (INCR) Stock News Today - TradingKey
InterCure Ltd (INCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intercure Ltd. Ordinary Shares Share Price Live Today – NASDAQ:INCR Stock Price, Chart, News, History - Upstox
Intercure (INCR) Slips 1.16% to $0.95, Hovering Above Key SupportRVOL Spike - dars.gov.et
Intercure Details Voting Procedures for August 11 Extraordinary Shareholder Meeting - TipRanks
InterCure (INCR) sets voting process for August 11 extraordinary shareholder meeting - Stock Titan
INCR Q2 2023 Earnings: EPS Surprises to the Upside Despite Stock DeclineAdjusted Earnings Analysis - vinanet.vn
InterCure Ltd. Revenue Breakdown – TASE:INCR - TradingView
InterCure Ltd (INCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InterCure Ltd (INCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InterCure Ltd (INCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
InterCure Ltd (INCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
InterCure Ltd (INCR) Income Statement - TradingKey
INCR|InterCure Ltd|Price:0.939|Chg%:-0.020 - TradingKey
INCR|InterCure Ltd|Price:0.927|Chg%:+0.025 - TradingKey
InterCure Ltd (INCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
INCR Q2 2023 Earnings: EPS Surprises to the Upside as Profitability Exceeds ExpectationsHealthcare Earnings Report - vinanet.vn
What Is Driving InterCure (NASDAQ:INCR) on the Nasdaq? - Kalkine Media
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% as Stock GainsRevenue Growth Outlook - dars.gov.et
InterCure (INCR) seeks approval for 5-for-1 reverse share split - Stock Titan
Alexander Rabinovich Net Worth (2026) - GuruFocus
Lennie Grinbaum Michelson Net Worth (2026) - GuruFocus
INCR Q2 2023 Earnings: EPS Surprise Beats Estimates Amid Undisclosed RevenueAnnual Earnings Summary - vinanet.vn
Price to book forward of Intercure Ltd. – NASDAQ:INCR - TradingView
ETFs Investing in InterCure Ltd. Stocks - TradingView
Intercure Ltd (INCR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):